The best indicator for RTX Corporation (RTX)
We backtested 20 indicators across daily, weekly and hourly charts on real RTX Corporation (RTX) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
MACD
On the weekly chart, this is the strongest risk-adjusted edge we found for RTX Corporation (RTX) over ~64.4 years — trailing buy-and-hold by 4.3% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | MACD ✓ | Weekly | 8.4% | 0.52 | -63.1% | 50.4% | 125 | -4.3% |
| 2 | RSI Trend (>50) ✓ | Weekly | 8.5% | 0.52 | -48.9% | 50.0% | 174 | -4.1% |
| 3 | EMA 20/50 Cross ✓ | Daily | 8.3% | 0.51 | -47.1% | 43.4% | 145 | -4.3% |
| 4 | EMA 50/200 Cross ✓ | Daily | 7.5% | 0.46 | -48.9% | 48.8% | 43 | -5.1% |
| 5 | Donchian Breakout ✓ | Weekly | 6.8% | 0.46 | -48.0% | 50.9% | 53 | -5.9% |
| 6 | Donchian Midline ✓ | Weekly | 7.3% | 0.46 | -40.8% | 50.5% | 188 | -5.4% |
| 7 | RSI Trend (>50) ✓ | Daily | 6.4% | 0.42 | -72.4% | 37.3% | 875 | -6.2% |
| 8 | EMA 20/50 Cross ✓ | Weekly | 7.1% | 0.42 | -61.7% | 53.6% | 28 | -5.6% |
| 9 | SMA 50/200 Cross ✓ | Daily | 6.3% | 0.4 | -60.8% | 53.3% | 45 | -6.3% |
| 10 | EMA-10 Trend ✓ | Weekly | 6.1% | 0.4 | -53.4% | 50.5% | 299 | -6.5% |
| 11 | Rate of Change ✓ | Daily | 5.7% | 0.39 | -65.2% | 43.1% | 1044 | -6.9% |
| 12 | Bollinger Breakout ✓ | Weekly | 5.0% | 0.39 | -51.2% | 46.9% | 64 | -7.7% |
| 13 | Donchian Breakout ✓ | Daily | 5.0% | 0.38 | -45.5% | 48.7% | 263 | -7.6% |
| 14 | Heikin-Ashi Trend | Daily | 5.6% | 0.38 | -85.1% | 44.1% | 3068 | -7.0% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For RTX Corporation (RTX), MACD on the weekly timeframe gave the best balance of return and risk in our test. It still trailed buy-and-hold on raw return — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.